TuHURA’s TBS-2025 Receives FDA IND Clearance for AML
San Diego, California, U.S., September 14, 2026 TuHURA Biosciences has announced that the U.S. Food and Drug Administration (FDA)...
drug safety
Advertisement
Amgen’s IMDELLTRA Gets Reduced FDA Monitoring Time
Thousand Oaks, California, U.S., September 14, 2026 Amgen announced that the U.S. Food and Drug Administration (FDA) has approved...
Bridge to Life Raises $110M to Expand Organ Perfusion
DULUTH, Georgia, August 12, 2026 Bridge to Life Ltd., a medical technology company specializing in organ preservation and perfusion...
Eli Lilly Escalates Fight Against Illegal Retatrutide Market
INDIANAPOLIS, Indiana, August 12, 2026 Eli Lilly and Company has intensified its efforts to combat the illegal sale of...
Novo Nordisk’s Denecimig Shows Strong Phase 3 Hemophilia Data
PLAINSBORO, New Jersey, USA / BAGSVÆRD, Denmark, July 11, 2026 Novo Nordisk has announced positive long-term Phase 3 results...
Advertisements
FDA Proposes New Rule to Modernize Drug Manufacturing
SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...
FDA Releases Pregnancy Safety Guidance for Drugs and Biologics
WASHINGTON, D.C., United States – May 8, 2026 The U.S. Food and Drug Administration announced the release of a...
MHRA Seizes 20M Illegal ED Pills in UK Crackdown
LONDON, UNITED KINGDOM — February 13, 2026 The Medicines and Healthcare products Regulatory Agency (MHRA) has seized nearly 20...
HUYABIO Reports Positive Phase 1 Data for AF Drug HBI-3000
SAN DIEGO | January 6, 2026 — HUYABIO International has announced positive Phase 1 clinical results for HBI-3000, a...
FDA Clears Path Forward for Vanda’s Motion-Sickness Drug Development
WASHINGTON, D.C., December 4, 2025 — The U.S. Food and Drug Administration (FDA) has lifted its partial clinical hold...
Advertisement
